Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Neurodiagnostics Market From 2025 To 2029?
Recent years have seen a robust expansion in the size of the neurodiagnostics market. It is projected to swell from $9.17 billion in 2024 to $9.79 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. This growth during the historical period can be ascribed to several factors, including a surge in the prevalence of neurological disorders, escalated adoption of advanced imaging technologies, a swelling geriatric population, heightened awareness of early disease detection, expanding healthcare infrastructure, and increased investment in neuroscience research and development.
The size of the neurodiagnostics market is forecasted to undergo substantial growth in the upcoming years, swelling to $12.68 billion by 2029, climbing at a compound annual growth rate (CAGR) of 6.7%. This growth during the projection period can be ascribed to the rising demand for non-invasive diagnostic methods, the increasing instances of neurological disorders, the escalation in government funding in healthcare facilities, heightened awareness and early detection initiatives, and the broadening of personalized medicine strategies. Notable trends during the forecasting period encompass the emergence of portable EEG devices, the incorporation of AI to enhance diagnostic preciseness, improved MRI techniques for brain imaging, the integration of wearable technology for continuous monitoring, progression in neurogenetic testing, and the implementation of real-time data analysis for individualized treatment schedules.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20902&type=smp
What Are the Core Market Drivers Propelling Growth in the Neurodiagnostics Industry?
The surge in neurological disorders is projected to fuel the expansion of the neurodiagnostics market in the future. Neurological disorders affect the brain, spinal cord, and nerves, leading to cognitive, motor, and sensory impairments. Aging populations, environmental factors, lifestyle shifts, genetics, and enhanced diagnostic methods all contribute to the increase in neurological disorders. Neurodiagnostics are critical for accurately identifying, evaluating, and tracking neurological disorders, allowing for accurate diagnosis, informed treatment strategies, and efficient management of brain, spinal cord, and nerve disorders. For example, in April 2023, the National Library of Medicine, a US-based library for medical research data, reported that 6.7 million Americans were affected by Alzheimer’s in 2023, and this figure is predicted to rise to 13.8 million by 2060. Hence, the increased prevalence of neurological disorders is propelling the growth of the neurodiagnostics market.
How Is the Neurodiagnostics Market Segmented?
The neurodiagnosticsmarket covered in this report is segmented –
1) By Type: Diagnostic And Imaging Solutions; In-Vitro Diagnostics
2) By Technology: Neuroimaging Technologies; Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Nuclear Medicine Imaging (PET, SPECT); Near Infrared Spectroscopic Imaging (NIRS); Electro-Encephalography (EEG); Magneto-Encephalography (MEG); Voxel Based Morphometry (VBM); Neuroinformatics
3) By Condition: Epilepsy; Alzheimer’s Disease; Parkinson’s Disease; Stroke; Joint Health; Other Conditions
4) By End Use : Hospitals And Clinics; Diagnostic Laboratories; Imaging Centers; Other End Uses
Subsegments:
1) By Diagnostic And Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems; CT (Computed Tomography) Scanners; EEG (Electroencephalogram) Systems; EMG (Electromyography) Systems; MEG (Magnetoencephalography) Systems; PET (Positron Emission Tomography) Scanners; SPECT (Single Photon Emission Computed Tomography) Scanners; Functional MRI (fMRI) Systems; Intracranial Pressure Monitors
2) By In-Vitro Diagnostics: Blood-Based Diagnostics; Cerebrospinal Fluid (Csf) Analysis; Genetic Testing And Biomarkers; Neurochemical Diagnostics; Point-Of-Care Neurodiagnostics; Diagnostic Kits For Neurodegenerative Disorders
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20902&type=smp
Which Regions Are Driving the Next Phase of the Neurodiagnostics Market Growth?
North America was the largest region in the neurodiagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Neurodiagnostics Industry?
Top-tier businesses in the neurodiagnostics market are emphasising on technological innovations like sophisticated software algorithms to augment diagnostic precision and enhance patient results. The advanced software algorithm is a complex command set which utilises artificial intelligence (AI) or machine learning techniques to process and interpret data, thereby aiding in decision-making and diagnosis. For instance, Ceribell Inc., a medical equipment manufacturer from the US, in October 2023, initiated the ClarityPro AI algorithm that marked considerable progress in the electrographic status epilepticus (ESE) detection. This groundbreaking software incorporated in the Ceribell EEG system employs machine learning to scrutinise EEG waveforms and issue instantaneous alerts for potential seizures. Importantly, ClarityPro has the distinction of being the first acute care appliance to secure FDA approval for independent diagnosis. This cutting-edge technology is crafted to refine clinical judgment via continuous brain activity monitoring, providing actionable intelligence and facilitating swifter and efficient treatment reactions.
View the full report here:
https://www.thebusinessresearchcompany.com/report/neurodiagnostics-global-market-report
How Is the Neurodiagnostics Market Defined and What Are Its Core Parameters?
Neurodiagnostics refers to the medical field focused on diagnosing and monitoring disorders of the nervous system, including the brain, spinal cord, and peripheral nerves. It involves the use of advanced technologies and tests to assess neurological function, identify abnormalities, and aid in the diagnosis of conditions such as epilepsy, stroke, multiple sclerosis, neuropathies, and other neurological diseases.?
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20902
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model